Back
Berkshire Hathaway Vs. Blueprint Medicines Industry Stock Comparison
Sell
22
BRK.B
Berkshire Hathaway
Last Price:
$450.09
Seasonality Move:
5.18%
Sell
40
BPMC
Blueprint Medicines
Last Price:
$102.47
Seasonality Move:
5.27%
Sell
22
Berkshire Hathaway (BRK.B)
is a Sell
Is Berkshire Hathaway a Buy, Sell or Hold?
-
The current Berkshire Hathaway [BRK.B] share price is $450.03. The Score for BRK.B is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
BRK.B is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $102.56. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRK.B Stock Price Chart
What is Berkshire Hathaway's stock price today?
-
The Berkshire Hathaway share price today is $450.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.B is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $102.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.
BRK.B Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.03 | Sell |
Relative Strength Index (14 RSI): | 43.85 | Sell |
Chaikin Money Flow: | 3698970 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (448.55 - 460.75) | Sell |
Bollinger Bands (100): | (450.63 - 468.73) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.85 | Buy |
Relative Strength Index (14 RSI): | 63.82 | Buy |
Chaikin Money Flow: | -913925 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.06 - 96.6) | Buy |
Bollinger Bands (100): | (86.99 - 95.95) | Buy |
BRK.B Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 449.68 | Buy |
20-day SMA: | 452.47 | Sell |
50-day SMA: | 461.12 | Sell |
200-day SMA: | 437.81 | Buy |
8-day EMA: | 449.38 | Buy |
20-day EMA: | 453.32 | Sell |
50-day EMA: | 457.24 | Sell |
200-day EMA: | 437.36 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.93 | Buy |
20-day SMA: | 91.76 | Buy |
50-day SMA: | 93.83 | Buy |
200-day SMA: | 96.87 | Buy |
8-day EMA: | 94.89 | Buy |
20-day EMA: | 92.92 | Buy |
50-day EMA: | 92.72 | Buy |
200-day EMA: | 91.71 | Buy |
Berkshire Hathaway Earnings Growth & BRK.B Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.63 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.
Berkshire Hathaway Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |